Joline Beulens is Professor of Lifestyle and Cardiometabolic Disease Epidemiology at the Department of Epidemiology & Data Science of Amsterdam UMC. She leads the group on 'Lifestyle and Chronic Disease Epidemiology'. The main focus of her research is on aetiology and prevention of cardiometabolic diseases with a specific focus on the role of health behaviours. She uses large observational studies to quantify the association of different risk factors or exposures with the occurrence type 2 diabetes and cardiovascular diseases or to accurately predict those with a high risk of developing those diseases. Intervention studies are used to confirm observed associations and prevent occurrence of cardiometabolic diseases. She is PI of CVON Supreme Nudge consortium investigating the role of nudging, pricing and a physical activity app on cardiometabolic risk in people with low socioeconomic position. Joline Beulens is (past) editor of several international journals like Diabetologia, European Journal of Preventive Cardiology and British Journal of Nutrition. She is member of the nutrition council of the Dutch Health Council and past president of the Dutch Academy of Nutritional Sciences (2016-2018).
de Pinho MGM, Mackenbach JD, den Braver NR, Beulens J, Brug J, Lakerveld J.
International Journal of Behavioral Nutrition and Physical Activity volume 17, Article number: 43 (2020)
den Braver NR, Kok JG, Mackenbach JD, Rutter H, Oppert J-M, Compernolle S, Twisk JWR, Brug J, Beulens JWJ, Lakerveld, J.
International Journal of Behavioral Nutrition and Physical Activity volume 17, Article number: 8 (2020)
Dal Canto E, Ceriello A, Rydén L, Ferrini M, Hansen TB, Schnell O, Standl E, Beulens JW.
Eur J Prev Cardiol. 2019 Dec;26(2_suppl):25-32.
Hoenink JC, Lakerveld J, Rutter H, Compernolle S, De Bourdeaudhuij I, Bárdos H, Charreire H, Oppert JM, Mackenbach JD.
Obes Facts . 2019;12(1):14-24. doi: 10.1159/000496118. Epub 2019 Jan 23.
Mackenbach JD, Lakerveld J, Generaal E, Gibson-Smith D, Penninx BWJH , Beulens JWJ.
Eur J Nutr . 2019 Dec;58(8):3129-3134. doi: 10.1007/s00394-018-1857-0. Epub 2018 Nov 13.
den Braver NR, Lakerveld J, Rutters F, Schoonmade LJ, Brug J, Beulens JWJ.
BMC Med. 2018 Jan 31;16(1):12.
Kengne AP, Beulens JW, Peelen LM, ….., Wareham NJ.
Lancet Diabetes Endocrinol. 2014 Jan;2(1):19-29.
We know far less about the exposome than we do about the human genome. So far, we only understand about half of the disease burden for which we know the environment plays a role. If we want to prevent people from becoming ill, then we need to understand the other half too. We therefore want to systematically analyse the exposome for the first time. We will start with research into the causes of cardiovascular disease and type 2 diabetes. The techniques and insights from this research will also be applicable to other chronic conditions.Read More